From: The effect of tobacco, XPC, ERCC2 and ERCC5 genetic variants in bladder cancer development
 |  |  |  |  |  |  |  | 95% Confidence Interval for Exp(B) | |
---|---|---|---|---|---|---|---|---|---|
groupa | B | Standard error | Wald | Df | P value | Exp (B) = OR | Lower Bound | Upper Bound | |
Cases | Intercept | -1,10 | 1,08 | 1,03 | 1 | ,31 | Â | Â | Â |
 | Sex | ,30 | ,42 | ,53 | 1 | ,46 | 1,36 | ,59 | 3,11 |
 | Age range | 1,82 | ,39 | 21,99 | 1 | ,00 | 6,22 | 2,89 | 13,35 |
 | [XPC (A/C) = AA] | -,85 | ,34 | 6,06 | 1 | ,01 | ,42 | ,21 | ,84 |
 | [XPC (A/C) = AC] | -1,01 | ,34 | 8,80 | 1 | ,00 | ,36 | ,18 | ,70 |
 | [XPC (A/C) = CC] | 0b | . | . | 0 | . | . | . | . |
 | [ERCC2 (A/C) = AA] | ,12 | ,40 | ,10 | 1 | ,75 | 1,13 | ,51 | 2,51 |
 | [ERCC2 (A/C) = AC] | -,16 | ,40 | ,15 | 1 | ,69 | ,85 | ,38 | 1,90 |
 | [ERCC2 (A/C) = CC] | 0b | . | . | 0 | . | . | . | . |
 | [ERCC5 (G/C) = CC] | ,55 | ,38 | 2,11 | 1 | ,14 | 1,74 | ,82 | 3,71 |
 | [ERCC5 (G/C) = GC] | -,22 | ,24 | ,85 | 1 | ,35 | ,79 | ,49 | 1,29 |
 | [ERCC5 (G/C) = GG] | 0b | . | . | 0 | . | . | . | . |
 | [Tobacco PY = 0] | -1,18 | ,32 | 13,03 | 1 | ,00 | ,30 | ,16 | ,58 |
 | [Tobacco PY = 1-19] | -1,97 | ,45 | 19,17 | 1 | ,00 | ,13 | ,05 | ,33 |
 | [Tobacco PY ≥ 20] | 0b | . | . | 0 | . | . | . | . |